日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC

靶向NHEJ可通过MYC降解激活STING信号通路,从而增强小细胞肺癌的抗肿瘤免疫力。

Chakraborty, Subhamoy; Elliott, Andrew; Sen, Utsav; Coleman, Charles; Jethalia, Vrinda; Ventura, Kedwin; Fan, Chih-Wei; Sritharan, Ramja; Banerjee, Avisek; Mahendravarman, Yazhini; Vanderwalde, Ari; Halmos, Balazs; de Stanchina, Elisa; Taniguchi, Hirokazu; Demircioglu, Deniz; Hasson, Dan; Sen, Triparna

Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies

非小细胞肺癌靶向治疗的耐受性和耐药性:新兴概念和策略

Sanchez-Cespedes, Montse; Lockwood, William W; Suda, Kenichi; Gardner, Eric E; Mitsudomi, Tetsuya; Politi, Katerina; Rolfo, Christian; Sen, Triparna; Sos, Martin L; Tammela, Tuomas; Wynes, Murry W; Tsao, Ming Sound; Berger, Alice H

Unlocking KRAS: Navigating Its Molecular Biology and Treatment Landscape Among Gastrointestinal Malignancies

揭开 KRAS 的神秘面纱:探索其在胃肠道恶性肿瘤中的分子生物学和治疗格局

Frisch, Austin; Martin, Eric; Cannon, Timothy; Wadlow, Raymond; Raghavan, Srivatsan; Sen, Triparna; Karim, Nagla Abdel

ATM functions as a rheostat of metabolic stress in small-cell lung cancer.

ATM 在小细胞肺癌中起到代谢应激调节器的作用。

Halder Debdatta, Sen Utsav, Jethalia Vrinda, Chakraborty Subhamoy, Elliott Andrew, Ventura Kedwin, Vanderwalde Ari, Halmos Balazs, Borghaei Hossein, Thin Tin Htwe, Soto Alan, Berisa Mirela, Brody Rachel, Demircioglu Deniz, Hasson Dan, Sen Triparna

Histologic Transformation in Cancer: The Path for Clinical Translation

癌症的组织学转化:通往临床转化的路径

Vathiotis, Ioannis; Banerjee, Avisek; Sen, Utsav; Saalfeld, Felix C; Halder, Debdatta; Charpidou, Andriani; Syrigos, Konstantinos N; Horinouchi, Hidehito; Tewari, Ashutosh K; Dawson, Mark A; Wermke, Martin; Sen, Triparna

Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC

2025年肺癌基础和转化研究进展——概述与展望(聚焦非小细胞肺癌)

Mascaux, Celine; Sen, Triparna; Sanchez-Cespedes, Montse; Ortiz-Cuaran, Sandra; Bossé, Yohan; Dammeijer, Floris; Cavic, Milena; Barr, Martin P; Arulananda, Surein; Armisen, Ricardo; Berger, Alice H; Bianchi, Fabrizio; Carbone, David P; Cerciello, Ferdinando; Lockwood, William W; Mitsudomi, Tetsuya; Ohara, Shuta; Politi, Katerina; Qin, Sida; Roisman, Laila C; Samstein, Robert; Skoulidis, Ferdinandos; Tan, Aaron C; Thomas, Anish; Zhang, Jianjun; Wynes, Murry W; John, Thomas; Tsao, Ming Sound

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Luribinectedin 通过激活小细胞肺癌中的 STING-IFN 信号通路来增强 PD-L1 阻断疗法的敏感性

Chakraborty, Subhamoy; Sen, Utsav; Ventura, Kedwin; Jethalia, Vrinda; Coleman, Charles; Sridhar, Subhasree; Banerjee, Avisek; Ozakinci, Hilal; Mahendravarman, Yazhini; Snioch, Konrad; de Stanchina, Elisa; Shields, Misty D; Tomalin, Lewis E; Demircioglu, Deniz; Boyle, Theresa A; Tocheva, Anna; Hasson, Dan; Sen, Triparna

Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis

小细胞肺癌脑转移患者的生存决定因素和治疗结果:一项美国全国性分析

Qidwai, Khalid Ahmad; Sarfraz, Zouina; Mustafayev, Khalis; Hodgson, Lydia C; Maharaj, Arun; Sen, Triparna; Ranjan, Tulika; Ahluwalia, Manmeet S

KRAS mutated NSCLC: past, present, and future directions in a rapidly evolving landscape

KRAS突变型非小细胞肺癌:快速演变的格局中的过去、现在和未来方向

Frisch, Austin; Martin, Eric; Kim, So Yeon; Riess, Jonathan W; Sen, Triparna; Karim, Nagla

Antibody drugs conjugates in non-small cell lung cancer: current status and challenges

抗体药物偶联物在非小细胞肺癌中的应用:现状与挑战

Syal, Arjun; Meyer, May-Lucie; Angelino, Kenneth; Osei, Noah; Gomez, Jorge E; Sen, Triparna; Hirsch, Fred R